UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $357,000 Position in USANA Health Sciences, Inc. (NYSE:USNA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 42.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,423 shares of the company’s stock after selling 6,810 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in USANA Health Sciences were worth $357,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. KBC Group NV grew its stake in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after buying an additional 519 shares during the period. BOKF NA boosted its holdings in USANA Health Sciences by 99.4% in the second quarter. BOKF NA now owns 5,526 shares of the company’s stock worth $250,000 after acquiring an additional 2,755 shares in the last quarter. Quest Partners LLC acquired a new stake in USANA Health Sciences in the third quarter valued at approximately $250,000. Exchange Traded Concepts LLC increased its holdings in shares of USANA Health Sciences by 4.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after acquiring an additional 322 shares in the last quarter. Finally, Harbor Capital Advisors Inc. raised its position in shares of USANA Health Sciences by 44.1% during the third quarter. Harbor Capital Advisors Inc. now owns 8,859 shares of the company’s stock worth $336,000 after purchasing an additional 2,713 shares during the period. 54.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. DA Davidson raised shares of USANA Health Sciences to a “hold” rating in a research report on Friday. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Thursday.

USANA Health Sciences Stock Down 3.8 %

Shares of USANA Health Sciences stock opened at $33.38 on Friday. USANA Health Sciences, Inc. has a 52 week low of $33.28 and a 52 week high of $54.81. The business has a 50 day moving average price of $37.91 and a 200-day moving average price of $40.37. The company has a market cap of $636.22 million, a PE ratio of 11.80, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The business had revenue of $200.22 million for the quarter, compared to analysts’ expectations of $208.45 million. During the same period last year, the business earned $0.59 EPS. As a group, research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Buying and Selling at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction on Monday, November 4th. The stock was sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.33% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.